« Back
Home /
SSA antigenic peptide

SSA antigenic peptide

Item no.	HY-P4155-1ea
Manufacturer	MedChem Express
Amount	1 ea
Category	Peptides & Proteins Recombinant Proteins Immunization
Type	Antigen
Specific against	other
Purity	99.37
Formula	C78H133N23O21S.0.15C2HF3O2
Citations	[1]Xiao F, et al. Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome. Cell Mol Immunol. 2017 Jul 10;14(11):924–34.
Smiles	[O=C(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@@H](CC(O)=O)C(N[C@@H]([C@@H](C)CC)C(N2[C@@H](CCC2)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N.[O]C(C(F)(F)F)=O]
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352202
Available
Product Description	SSA antigenic peptide is an antigenic peptide of Sjögren’s syndrome-related antigen A (SSA)[1].
StorageTemperature	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Shipping	Blue Ice
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	1777.08
Clinical_Information	No Development Reported
Manufacturers Research_Area	Inflammation/Immunology
Solubility	H2O
Manufacturers Target	Others
Pathway	Others
Manufacturers Product type	Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 ea

available

Request delivery time